Nishio K - Search Results

1

Functional Analyses of Mutations in Receptor Tyrosine Kinase Genes in Non-Small Cell Lung Cancer: Double-Edged Sword of DDR2.

Terashima M, Togashi Y, Sato K, Mizuuchi H, Sakai K, Suda K, Nakamura Y, Banno E, Hayashi H, De Velasco MA, Fujita Y, Tomida S, Mitsudomi T, Nishio K. Terashima M, et al. Among authors: nishio k. Clin Cancer Res. 2016 Jul 15;22(14):3663-71. doi: 10.1158/1078-0432.CCR-15-2093. Epub 2016 Jan 29. Clin Cancer Res. 2016. PMID: 26826182

2

Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin.

Kasahara K, Fujiwara Y, Nishio K, Ohmori T, Sugimoto Y, Komiya K, Matsuda T, Saijo N. Kasahara K, et al. Among authors: nishio k. Cancer Res. 1991 Jun 15;51(12):3237-42. Cancer Res. 1991. PMID: 1645616

3

Modulation of cisplatin sensitivity and accumulation by amphotericin B in cisplatin-resistant human lung cancer cell lines.

Morikage T, Ohmori T, Nishio K, Fujiwara Y, Takeda Y, Saijo N. Morikage T, et al. Among authors: nishio k. Cancer Res. 1993 Jul 15;53(14):3302-7. Cancer Res. 1993. PMID: 8391922

4

Anticancer effects of ZD6474, a VEGF receptor tyrosine kinase inhibitor, in gefitinib ("Iressa")-sensitive and resistant xenograft models.

Taguchi F, Koh Y, Koizumi F, Tamura T, Saijo N, Nishio K. Taguchi F, et al. Among authors: nishio k. Cancer Sci. 2004 Dec;95(12):984-9. doi: 10.1111/j.1349-7006.2004.tb03187.x. Cancer Sci. 2004. PMID: 15596048 Free PMC article.

5

Small in-frame deletion in the epidermal growth factor receptor as a target for ZD6474.

Arao T, Fukumoto H, Takeda M, Tamura T, Saijo N, Nishio K. Arao T, et al. Among authors: nishio k. Cancer Res. 2004 Dec 15;64(24):9101-4. doi: 10.1158/0008-5472.CAN-04-2360. Cancer Res. 2004. PMID: 15604279

6

Establishment of a human non-small cell lung cancer cell line resistant to gefitinib.

Koizumi F, Shimoyama T, Taguchi F, Saijo N, Nishio K. Koizumi F, et al. Among authors: nishio k. Int J Cancer. 2005 Aug 10;116(1):36-44. doi: 10.1002/ijc.20985. Int J Cancer. 2005. PMID: 15761868

7

Gefitinib treatment affects androgen levels in non-small-cell lung cancer patients.

Nishio M, Ohyanagi F, Horiike A, Ishikawa Y, Satoh Y, Okumura S, Nakagawa K, Nishio K, Horai T. Nishio M, et al. Among authors: nishio k. Br J Cancer. 2005 May 23;92(10):1877-80. doi: 10.1038/sj.bjc.6602585. Br J Cancer. 2005. PMID: 15870715 Free PMC article. Clinical Trial.

8

Enhancement of sensitivity to tumor necrosis factor alpha in non-small cell lung cancer cells with acquired resistance to gefitinib.

Ando K, Ohmori T, Inoue F, Kadofuku T, Hosaka T, Ishida H, Shirai T, Okuda K, Hirose T, Horichi N, Nishio K, Saijo N, Adachi M, Kuroki T. Ando K, et al. Among authors: nishio k. Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8872-9. doi: 10.1158/1078-0432.CCR-05-0811. Clin Cancer Res. 2005. PMID: 16361577

9

Dimerization and the signal transduction pathway of a small in-frame deletion in the epidermal growth factor receptor.

Sakai K, Arao T, Shimoyama T, Murofushi K, Sekijima M, Kaji N, Tamura T, Saijo N, Nishio K. Sakai K, et al. Among authors: nishio k. FASEB J. 2006 Feb;20(2):311-3. doi: 10.1096/fj.05-4034fje. Epub 2005 Dec 22. FASEB J. 2006. PMID: 16373402

10

In-frame deletion in the EGF receptor alters kinase inhibition by gefitinib.

Sakai K, Yokote H, Murakami-Murofushi K, Tamura T, Saijo N, Nishio K. Sakai K, et al. Among authors: nishio k. Biochem J. 2006 Aug 1;397(3):537-43. doi: 10.1042/BJ20051962. Biochem J. 2006. PMID: 16623663 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,208 results

Search Page

Filters